Back to search
Scientific Name: Copanlisib
Brand Name: Aliqopa
Company Owner: Not Available
Mechanism Of Action Follicular lymphoma is a B-cell lymphoma that is one of the most common type of non-Hodgkin lymphoma (NHL) . It involves unregulated growth and proliferation of lymphocytes that eventually may travel to other organs including the lymph nodes, spleen, and the bone marrow, to form tumors. The phosphatidylinositol 3-kinase (PI3K) -mediated pathway is involved in promoting cell survival proliferation and differentiation however abberant activation of this pathway may lead to tumorigenesis
Description of the Drug: Copanlisib is a medication used to treat relapsed follicular lymphoma who have attempted at least two other treatments.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from